A detailed history of Archford Capital Strategies, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 3,464 shares of ABT stock, worth $395,692. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,464
Previous 3,627 4.49%
Holding current value
$395,692
Previous $376,000 4.79%
% of portfolio
0.06%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$100.07 - $118.13 $16,311 - $19,255
-163 Reduced 4.49%
3,464 $394,000
Q2 2024

Jul 17, 2024

BUY
$100.73 - $112.44 $7,252 - $8,095
72 Added 2.03%
3,627 $376,000
Q1 2024

Apr 24, 2024

BUY
$109.52 - $120.96 $33,841 - $37,376
309 Added 9.52%
3,555 $404,000
Q4 2023

Jan 12, 2024

SELL
$90.19 - $110.4 $211,585 - $258,998
-2,346 Reduced 41.95%
3,246 $357,000
Q3 2023

Oct 27, 2023

SELL
$95.53 - $114.62 $16,813 - $20,173
-176 Reduced 3.05%
5,592 $541,000
Q2 2023

Aug 02, 2023

BUY
$100.78 - $112.29 $403 - $449
4 Added 0.07%
5,768 $628,000
Q1 2023

Apr 18, 2023

BUY
$96.86 - $114.01 $144,224 - $169,760
1,489 Added 34.83%
5,764 $583,000
Q4 2022

Jan 26, 2023

SELL
$95.06 - $111.52 $26,616 - $31,225
-280 Reduced 6.15%
4,275 $0
Q3 2022

Oct 17, 2022

BUY
$96.76 - $112.03 $16,642 - $19,269
172 Added 3.92%
4,555 $441,000
Q2 2022

Jul 12, 2022

SELL
$102.07 - $123.37 $207,712 - $251,057
-2,035 Reduced 31.71%
4,383 $476,000
Q1 2022

Apr 18, 2022

SELL
$114.02 - $139.04 $113,107 - $137,927
-992 Reduced 13.39%
6,418 $767,000
Q4 2021

Jan 20, 2022

SELL
$115.53 - $141.46 $29,806 - $36,496
-258 Reduced 3.36%
7,410 $1.04 Million
Q3 2021

Oct 14, 2021

SELL
$116.66 - $129.06 $4,549 - $5,033
-39 Reduced 0.51%
7,668 $906,000
Q2 2021

Jul 23, 2021

SELL
$105.79 - $124.53 $80,083 - $94,269
-757 Reduced 8.94%
7,707 $893,000
Q1 2021

Apr 26, 2021

SELL
$108.84 - $128.23 $850,149 - $1 Million
-7,811 Reduced 47.99%
8,464 $1.05 Million
Q4 2020

Jan 19, 2021

BUY
$105.0 - $114.42 $40,215 - $43,822
383 Added 2.41%
16,275 $1.82 Million
Q3 2020

Oct 19, 2020

SELL
$91.64 - $111.29 $135,352 - $164,375
-1,477 Reduced 8.5%
15,892 $1.73 Million
Q2 2020

Jul 24, 2020

SELL
$76.57 - $98.0 $4,287 - $5,488
-56 Reduced 0.32%
17,369 $1.59 Million
Q1 2020

Apr 29, 2020

BUY
$62.82 - $91.86 $510,412 - $746,362
8,125 Added 87.37%
17,425 $1.38 Million
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $15,694 - $18,974
-237 Reduced 2.49%
9,300 $743,000
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $12,770 - $15,405
-210 Reduced 2.15%
9,537 $700,000
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $561,134 - $619,324
9,747 New
9,747 $594,000
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $549,307 - $621,058
-9,762 Closed
0 $0
Q4 2017

Feb 16, 2018

SELL
$53.68 - $57.47 $9,930 - $10,631
-185 Reduced 1.86%
9,762 $557,000
Q3 2017

Nov 17, 2017

BUY
$48.06 - $53.64 $1,682 - $1,877
35 Added 0.35%
9,947 $531,000
Q2 2017

Aug 25, 2017

BUY
N/A
9,468 Added 2132.43%
9,912 $482,000
Q2 2017

Aug 18, 2017

BUY
N/A
444
444 $55,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Archford Capital Strategies, LLC Portfolio

Follow Archford Capital Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.